News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘ColonCancer’ clear

  • Scientists have identified a genetic mutation in about 20 percent of colorectal and endometrial cancers that had been overlooked in recent large, comprehensive gene searches. With this discovery, the altered gene, called RNF43, now ranks as one of the most common mutations in the two cancer types.

Tags: ColonCancer, Genomics, GynecologicCancers

  • Cancer death rates in the United States continue to decline, according to the Annual Report to the Nation on the Status of Cancer, published online by the journal Cancer.

Tags: BreastCancer, ColonCancer, LungCancer, Prevention

  • A team of researchers, including those from Dana-Farber Cancer Institute, Brigham and Women's Hospital and the Harvard School of Public Health, will be reporting study findings that lend powerful scientific backing to the recommendation that people receive a colonoscopy screening to prevent colorectal cancer.

Tags: ColonCancer, Prevention, PopulationScience

  • Charles Fuchs, MD, MPH, director of the Center for Gastrointestinal Oncology at Dana-Farber Cancer Institute, said colorectal cancer can be detected early thanks to one simple screening test, a colonoscopy.

Tags: ColonCancer, Prevention

  • Dana-Farber Cancer Institute researchers report that when people with a family history of colorectal cancer develop the disease, their tumors often carry a molecular sign that the cancer could be life-threatening.

Tags: ColonCancer

  • A new study by Dana-Farber researchers shows aspirin therapy can extend the life of colorectal cancer patients whose tumors carry a mutation in a key gene, but has no effect on patients who lack the mutation.

Tags: ColonCancer, Genetics

  • Colorectal cancer is the second leading cause of cancer deaths in the United States. Many people have no symptoms in the early stages of the disease. Doctors are reminding people about the importance of being regularly screened to help save lives.

Tags: ColonCancer, Prevention

  • Newly discovered gene mutations in certain non-small cell and colorectal cancers share similarities with other genetic abnormalities that are known to respond to targeted cancer treatments. This suggests that existing therapies, already approved, could be used to treat patients with these tumors.

Tags: ColonCancer, Genomics, KinaseInhibitor, LungCancer, TargetedTherapy

  • Dana-Farber and the Broad Institute researchers have found high levels of the bacterium Fusobacterium in colorectal cancers, a sign that it might contribute to the disease and potentially lead to further research.

Tags: BasicResearch, ColonCancer, Genomics

  • Dana-Farber researchers have discovered how some cancer cells can evade the effect of cetuximab. This insight may explain why some cancers that initially respond to cetuximab become resistant to it, or how to overcome such resistance.

Tags: ColonCancer, EGFR, TargetedTherapy

Showing 1-10 of 24 items